Country Guide: Filing a Patent in Europe (EPO)

Europe is the world's second-largest consumer market and home to some of the most rigorous and commercially significant patent enforcement jurisdictions globally. A European patent — whether obtained through the EPO or through individual national offices — covers a market of over 700 million people across 44 countries and is essential for any inventor with genuine European commercial ambitions.

The European patent system is distinctive in ways that matter practically: it has a different examination philosophy from the USPTO, a different (and in some ways more powerful) set of enforcement tools, and since 2023 a fundamentally new mechanism — the Unitary Patent — that changes the calculus for pan-European protection. Understanding these differences is not academic. They determine how you draft your application, how you prosecute it, and how much protection you actually get.

The Hard Truth About European Patents

European patents are harder to get than US patents — and in many ways, that is a feature, not a bug.

The EPO's examination is genuinely rigorous. The problem-solution approach is methodical and demanding. Examiners expect explicit technical arguments, not general claims of novelty. The result is that a granted European patent has stronger presumptive validity than many US patents — it has survived a more demanding examination, and courts across Europe treat it accordingly.

The flip side: European prosecution is expensive. Translation costs, national validation fees, and annual renewal fees in each validated country mean the total cost of a European patent portfolio over its life is substantially higher than equivalent US protection. Many inventors file at the EPO, receive a positive search report, and then struggle with the cost of national phase validation — discovering that covering Germany, France, the UK, Italy, Spain, and the Netherlands requires six separate validation and renewal processes.

The Unitary Patent (launched June 2023) addresses part of this problem. But understanding the full landscape — EPC, Unitary Patent, national patents, and the Unified Patent Court — requires seeing how the pieces fit together before choosing a strategy.

The Architecture of European Patent Protection

European patent protection is not a single system. It is three overlapping systems that interact:

1. The European Patent Convention (EPC)

The EPC, administered by the European Patent Office (EPO) in Munich, is the framework under which European patent applications are examined. The EPO is not an EU institution — it covers 44 member states including all EU members plus non-EU countries such as the UK, Switzerland, Norway, Turkey, and others.

A European patent application is examined once at the EPO. Upon grant, it becomes a "bundle" of national patents — one for each EPC member state where the patent is validated. Each national patent is then governed by that country's national patent law and enforced in that country's courts.

Filing basis: The EPC does not grant a single enforceable patent. It grants a bundle of national patents that must be maintained separately.

2. The Unitary Patent (UP)

Introduced in June 2023, the Unitary Patent is a new option available to applicants at grant of a European patent. Instead of validating nationally in individual EU member states, the applicant can request unitary effect — a single patent right covering all 18 participating EU states simultaneously.

Coverage (as of 2025): 18 EU member states, including Germany, France, Italy, Netherlands, Belgium, Austria, Denmark, Finland, Sweden, and others. UK and Spain do not participate.

Key advantages of the Unitary Patent:

• Single annual renewal fee (currently set at the equivalent of the combined renewal fees for the four most commonly validated EPC states — Germany, France, UK, Netherlands)
• No per-country translation costs (except for a transitional period for certain languages)
• Single validation request instead of 18 national validations
• Enforcement through the new Unified Patent Court (UPC)

When a Unitary Patent is not the best choice:

• When only 1–3 specific European countries matter commercially (national validation in those countries is cheaper)
• When the UK is a priority market (UK is not in the Unitary Patent system; separate UK validation always needed)
• When there is risk of central invalidity — a Unitary Patent can be centrally revoked by the UPC, removing protection across all 18 states simultaneously, whereas a bundle of national patents requires separate invalidity proceedings in each country

3. National Patent Offices

Every EPC member state also has its own national patent office. Inventors can file directly at national offices — UK IPO, DPMA (Germany), INPI (France), etc. — rather than through the EPO. National filings are typically:

• Faster for simple inventions in one country
• Less expensive for single-country protection
• Useful when immediate national examination is needed before the EPO's timeline

For most inventors seeking protection in multiple European countries, the EPO route is more efficient. For protection in a single country, national filing may be preferable.

The Unified Patent Court (UPC)

The UPC began operations in June 2023 and represents the most significant change to European patent enforcement in decades. It is a supranational court with jurisdiction over both Unitary Patents and — critically — classical European patents in the UPC participating states.

What the UPC can do:

• Grant injunctions covering all UPC participating states with a single order
• Award damages for pan-European infringement in a single proceeding
• Invalidate a European patent across all UPC states with a single revocation action

The opt-out: During a transitional period (initially 7 years, potentially extended), owners of classical European patents can opt their patents out of UPC jurisdiction, keeping them under the exclusive jurisdiction of national courts. Once opted out, the patent cannot be enforced at the UPC — but also cannot be centrally revoked there.

Strategic calculus for opt-out:

• Opt out if: you have a valuable European patent that may be an infringement target; you fear a competitor filing a central revocation action that could remove your protection across all UPC states at once; you prefer to rely on established national courts (particularly Germany or the UK) with known jurisprudence
• Stay in if: you want the ability to enforce pan-European injunctions from a single court; your patent is strong and unlikely to face successful invalidity challenges; the efficiency of a single enforcement proceeding outweighs the central revocation risk

This opt-out decision must be made actively — it requires filing an opt-out request with the UPC before any infringement action is brought in a UPC member state. Failure to opt out leaves the patent exposed to UPC jurisdiction. Given the significance of this decision, early legal advice is essential for any inventor with a commercially important European patent portfolio.

EPO Examination: How It Differs from the USPTO

The EPO's examination philosophy differs from the USPTO's in ways that have direct practical consequences for how you draft and prosecute your application.

The Problem-Solution Approach

The EPO uses a structured methodology — the problem-solution approach — for assessing inventive step. Every obviousness rejection is framed within this structure, and every response to an obviousness rejection must engage with it.

The three steps:

1. Identify the closest prior art — the single prior art document that represents the most promising starting point for arriving at the claimed invention (typically the document that is most similar to the claimed invention and addresses the same problem)

1. Determine the objective technical problem — what technical problem does the claimed invention solve, starting from the closest prior art? This is not necessarily the subjective problem the inventor set out to solve — it is the objective problem defined by the technical differences between the claim and the closest prior art document

1. Assess obviousness — would a skilled person, starting from the closest prior art and motivated to solve the objective technical problem, have arrived at the claimed invention with a reasonable expectation of success?

Why this matters in practice:

The problem-solution approach is more structured than the US obviousness inquiry. It requires examiners to commit to a specific closest prior art document and a specific formulation of the technical problem — which gives applicants a clear target to attack in their responses. Arguments that the examiner has identified the wrong closest prior art, or that the objective technical problem should be differently formulated, can be decisive.

Strategic implication: When drafting for the EPO, frame the invention explicitly around a technical problem and technical solution. The specification should clearly identify what technical problem the invention solves and explain, in technical terms, how each claim element contributes to solving it. This is not just good prosecution practice — it is required by EPO guidelines.

Two-Part Claim Format

For inventions where a closest prior art document exists (almost always the case), the EPO expects claims in a two-part format:

Preamble: Features that are known from the closest prior art Characterising portion (introduced by "characterised in that" or "characterised by"): Features that distinguish the invention from the prior art

Example:

Single-part (US-style): "A valve comprising a housing, a closure element, and a pressure-actuated actuator configured to move the closure element between open and closed positions."

Two-part (EPO-style): "A valve comprising a housing and a closure element [preamble], characterised in that the valve comprises a pressure-actuated actuator configured to move the closure element between open and closed positions based on a fluid pressure threshold [characterising portion]."

The characterising portion contains the novel features. The EPO examiner's novelty and inventive step analysis focuses on these features. Drafting the characterising portion precisely — covering the core inventive concept without unnecessary limitations — is one of the most important skills in European patent prosecution.

What Is Not Patentable at the EPO

The EPO has explicit exclusions from patentability that differ from the US in important ways:

Discoveries, mathematical methods, mental acts, business methods, computer programs: Excluded "as such." The qualifier "as such" is important — an invention that uses a mathematical method or computer program to achieve a technical result may be patentable if it has technical character.

Methods of treatment of the human body: Methods of surgical or therapeutic treatment of the human body are excluded (Article 53(c) EPC). This covers methods of treatment but not medical devices, pharmaceutical compositions, or — importantly — "Swiss-type" second medical use claims (a form of claim specifically developed to allow patenting of new therapeutic uses of known compounds).

Plant and animal varieties: Excluded, along with essentially biological processes for producing plants or animals. However, technical processes for producing plants or animals (e.g., a specific laboratory technique) may be patentable.

Sufficiency of Disclosure (Article 83 EPC): The EPO's sufficiency requirement is demanding for broad claims. Claims to a genus of compounds require that the specification demonstrate the claimed breadth is achievable across the genus — not just for specific examples. Examiners in fields like biotechnology and chemistry apply this requirement rigorously.

The Rule 71(3) Communication and Grant

When the EPO examiner considers the application ready for grant, a Rule 71(3) communication is issued — a notice informing the applicant of the text proposed for the patent and the claims that will be granted. The applicant must approve the text (or request amendments within a strict 4-month period) before the patent can be granted.

This is not an automatic process. The applicant's attorney must review the proposed text carefully — particularly the claims — and decide whether to accept it or negotiate further. Errors in the approved text are difficult to correct after grant.

Filing Options and Routes to EPO Protection

Direct EPO Filing

File a European patent application directly at the EPO (epo.org/applying). All filing is done electronically through the EPO's online filing system. The application can be filed in English, French, or German — the three official EPO languages.

If filed in English: The application is examined in English. Upon grant, no translation of the claims is required into other EPO languages (since the London Agreement). Some individual EPC states require translation of the patent into their national language for national validation — but the significant translation burden that once characterised European patents has been substantially reduced.

PCT National Phase Entry

If you have filed a PCT application (see: How to File a Patent Internationally: The PCT Guide), you can enter the European national phase at the EPO within 31 months of the international filing date (the EPO offers a 31-month deadline, slightly longer than the standard 30-month PCT rule). The PCT application becomes a European application, and prosecution proceeds at the EPO.

The EPO's written opinion on the PCT application (issued by the EPO if it was the ISA) gives an early indication of how examination will proceed — a positive written opinion typically leads to faster grant.

Priority Date Strategy

The Paris Convention allows you to claim priority from an earlier national application filed within 12 months. If you filed a US provisional on 1 March 2025, you can file a European application (or PCT application designating Europe) by 1 March 2026, claiming the 1 March 2025 priority date.

This priority date determines what counts as prior art for your European application — anything published before 1 March 2025 (in this example) is prior art; anything published after is not. Crucially, the priority date is not the filing date — a competitor cannot destroy your European novelty by publishing between your US filing date and your EPO filing date, provided your European filing claims priority.

National Validation After EPO Grant

Once a European patent is granted (and assuming the applicant has not requested Unitary effect), the applicant must validate the patent in each EPC member state where national protection is desired. Validation involves:

1. Paying national validation fees (varies by country — typically EUR 50–900)
2. Submitting translations — some countries require translation of the patent (or at least the claims) into their national language. The London Agreement (signed by Germany, France, UK, Netherlands, Switzerland, and others) significantly reduced translation requirements. Non-London Agreement countries (Italy, Spain, Portugal, and others) still require full translations, which can cost EUR 3,000–10,000 per language.
3. Appointing local agents in countries that require national agent representation for patent maintenance

Typical validation choices and costs:

For most inventors, validation in Germany, France, UK, Netherlands, and one or two additional key markets covers the vast majority of European commercial value. Validating everywhere is expensive and often unnecessary — be strategic about which countries justify the ongoing renewal costs.

Annual Renewal Fees

Once validated nationally, each national patent requires annual renewal fees paid directly to the national patent office. These fees increase in later years and can represent a significant ongoing cost for a widely validated European portfolio.

Indicative annual renewal fees (approx., later years):

These accumulate across all validated countries. A patent validated in 8 European countries might cost EUR 5,000–8,000 per year in renewal fees alone in its later years. Review the portfolio at each renewal point and abandon validations in countries that no longer justify the cost.

Unitary Patent renewal fees: A single annual fee replaces all individual national renewal fees for the 18 participating UP states. The current fee schedule is tiered, rising to a maximum of approximately EUR 4,855 per year at years 14–20. This is broadly equivalent to the combined fees for the four most commonly validated EPC states — representing significant savings for broadly validated portfolios.

Enforcement Across Europe

Germany: The Engine of European Patent Enforcement

Germany remains the most important European patent enforcement jurisdiction by case volume. Three specialist patent courts — Düsseldorf (the busiest), Munich, and Mannheim — handle the vast majority of German patent infringement cases.

Key features of German patent enforcement:

• Bifurcation: Infringement proceedings and validity proceedings are handled in separate courts. An infringement court can grant an injunction without the validity court having reached a decision — creating a dynamic known as the "injunction gap" that has historically favoured patent holders
• Speed: Preliminary injunctions can be granted very quickly (days to weeks in urgent cases). First-instance decisions on the merits typically take 12–18 months
• Injunctions: German courts routinely grant injunctions covering the entire German market. An injunction from the Düsseldorf court is the most feared outcome for a party selling infringing products in Germany
• Cost: Infringement proceedings in Germany are generally less expensive than in the US or UK — total costs for a first-instance case typically range from EUR 100,000–500,000

The Netherlands: Cross-Border Injunctions

The Netherlands (particularly the courts in The Hague) has a strong tradition of granting cross-border injunctions covering multiple European countries. In principle, a Dutch court can grant an injunction that covers the activities of a defendant across all EU member states — though this has been contested and remains an evolving area of law.

The Unified Patent Court: The New Centre of Gravity

The UPC is designed to become the primary venue for pan-European patent disputes. Its Central Division (Paris, Munich, Milan) handles revocation actions; its Local Divisions (in Germany, Netherlands, France, Italy, Sweden, and other participating states) handle infringement actions.

UPC advantages:

• A single infringement action covering all UPC participating states
• Injunctions and damages covering the entire UP territory
• Access to disclosure of evidence tools not available in all national courts

Early UPC practice (2023–2025): The UPC's early decisions have been broadly favourable to patent holders — preliminary injunctions have been granted, and the court has shown willingness to engage with complex technical arguments. Both the Paris and Munich divisions of the Central Division have issued substantive decisions on validity. The court is developing a body of jurisprudence that practitioners expect to become more predictable over time.

A Worked Example: European Filing Strategy for a Mechanical Invention

Consider an inventor who has developed a novel sealing mechanism for industrial pipe connections. The invention is clearly patentable (confirmed by a professional prior art search), and the commercial market spans Germany, France, Italy, the Netherlands, and the UK.

Recommended strategy:

Month 0: File a UK provisional (quick, cheap, establishes UK priority date). Simultaneously file a German utility model for fast German protection within 6 months.

Month 10: File a PCT application designating EP (and China, Japan, USA). Claim priority from the UK provisional. This establishes a global priority date.

Month 30: Enter EPO national phase. File European application claiming PCT priority. Prosecution at the EPO begins.

Year 3–4: EPO grants the European patent. Request Unitary effect for coverage across 18 EU states. Separately validate in the UK (UK is not in the Unitary Patent system).

Result: Coverage across 18 EU states through the Unitary Patent (renewed with a single annual fee), plus separate UK patent. Germany, France, Italy, Netherlands, and the UK are all covered — efficiently and cost-effectively.

If the UK market is less critical, the UK validation cost can be deferred or eliminated. If Italy requires full Italian translation and the Italian market is minor, Italy can be omitted from national validation without affecting the Unitary Patent (which automatically covers Italy as one of the 18 UP states).

Sources

1. European Patent Office (EPO) — Official regional patent office; filing procedures, guidelines for examination, and fee schedules
2. European Patent Convention (EPC) — Full text of the convention governing European patent law
3. Unified Patent Court (UPC) — Official court website; rules of procedure, opt-out registry, and case law
4. EPO Unitary Patent Guide — Information on requesting unitary effect and renewal fees
5. WIPO — EPO Profile — Treaty memberships and office contact information

Information current as of April 2026. Patent fees, timelines, and office procedures change — verify with the national patent office before filing.